Eurobio Scientific (France) Performance
| ALERS Stock | 25.35 0.05 0.20% |
The firm shows a Beta (market volatility) of 0.34, which means possible diversification benefits within a given portfolio. As returns on the market increase, Eurobio Scientific's returns are expected to increase less than the market. However, during the bear market, the loss of holding Eurobio Scientific is expected to be smaller as well. At this point, Eurobio Scientific has a negative expected return of -0.0215%. Please make sure to confirm Eurobio Scientific's total risk alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if Eurobio Scientific performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Eurobio Scientific SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Eurobio Scientific is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors. ...more
| Begin Period Cash Flow | 65.6 M | |
| Total Cashflows From Investing Activities | -5.5 M |
Eurobio |
Eurobio Scientific Relative Risk vs. Return Landscape
If you would invest 2,580 in Eurobio Scientific SA on October 26, 2024 and sell it today you would lose (45.00) from holding Eurobio Scientific SA or give up 1.74% of portfolio value over 90 days. Eurobio Scientific SA is generating negative expected returns and assumes 1.2244% volatility on return distribution over the 90 days horizon. Simply put, 10% of stocks are less volatile than Eurobio, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Eurobio Scientific Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Eurobio Scientific's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Eurobio Scientific SA, and traders can use it to determine the average amount a Eurobio Scientific's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0176
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ALERS |
Estimated Market Risk
| 1.22 actual daily | 10 90% of assets are more volatile |
Expected Return
| -0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Eurobio Scientific is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Eurobio Scientific by adding Eurobio Scientific to a well-diversified portfolio.
Eurobio Scientific Fundamentals Growth
Eurobio Stock prices reflect investors' perceptions of the future prospects and financial health of Eurobio Scientific, and Eurobio Scientific fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Eurobio Stock performance.
| Return On Equity | 0.45 | |||
| Return On Asset | 0.23 | |||
| Profit Margin | 0.27 % | |||
| Operating Margin | 0.31 % | |||
| Current Valuation | 124.11 M | |||
| Shares Outstanding | 11.34 M | |||
| Price To Book | 1.31 X | |||
| Price To Sales | 1.30 X | |||
| Revenue | 185.32 M | |||
| EBITDA | 78.67 M | |||
| Cash And Equivalents | 102.39 M | |||
| Total Debt | 11.11 M | |||
| Book Value Per Share | 14.83 X | |||
| Cash Flow From Operations | 65.92 M | |||
| Earnings Per Share | 4.39 X | |||
| Total Asset | 209.87 M | |||
About Eurobio Scientific Performance
Assessing Eurobio Scientific's fundamental ratios provides investors with valuable insights into Eurobio Scientific's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Eurobio Scientific is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Eurobio Scientific performance evaluation
Checking the ongoing alerts about Eurobio Scientific for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Eurobio Scientific help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Eurobio Scientific generated a negative expected return over the last 90 days | |
| About 31.0% of the company shares are held by company insiders |
- Analyzing Eurobio Scientific's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Eurobio Scientific's stock is overvalued or undervalued compared to its peers.
- Examining Eurobio Scientific's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Eurobio Scientific's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Eurobio Scientific's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Eurobio Scientific's stock. These opinions can provide insight into Eurobio Scientific's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Eurobio Stock Analysis
When running Eurobio Scientific's price analysis, check to measure Eurobio Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eurobio Scientific is operating at the current time. Most of Eurobio Scientific's value examination focuses on studying past and present price action to predict the probability of Eurobio Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eurobio Scientific's price. Additionally, you may evaluate how the addition of Eurobio Scientific to your portfolios can decrease your overall portfolio volatility.